Do you want to read an article? Please log in or register.
CARTITUDE-1: Cilta-cel achieves long-term treatment-free remission in heavily pretreated patients with RRMM
Multiple Myeloma (MM)
EHA 2025
Related content
Lymphoma
Real-World Direct Comparison Shows Superiority of Axi-Cel over Liso-Cel in Patients with R/R LBCL
EHA 2025
Multiple Myeloma (MM)
REALiTAL: Retrospective analysis shows deep and durable responses with talquetamab in heavily pretreated patients with RRMM
EHA 2025
Leukemia
ZUMA-3: Long-term survival benefit with brexu-cel in patients with R/R B-ALL
Breast Cancer
Long term safety of controlled ovarian stimulation for fertility preservation prior to chemotherapy treatment in breast cancer patients
Fertil Steril
Shapira M, Sella T, Safrai M, Villain E, Lifshitz D, Orvieto R, Gal-Yam E, Meirow D
doi: 10.1016/j.fertnstert.2024.10.014
Skin Cancer
Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials
J Clin Oncol
Weber JS, Middleton MR, Yates G, Sharpe DJ, Kurt M, Lobo M, Moshyk A, Vanderpuye-Orgle J, Mohr P
doi: 10.1200/JCO.24.00237
Skin Cancer
Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients
Eur J Cancer
Robert C, Long GV, Larkin J, Wolchok JD, Hassel JC, Schadendorf D, Hodi FS, Lebbé C, Grob JJ, Hyngstrom JR, Wagstaff J, Chesney J, Butler MO, Bechter O, Márquez-Rodas I, Pavlick AC, Durani P, Pe Benito M, Wang P, Postow MA, Ascierto PA
doi: 10.1016/j.ejca.2024.115119
CHICAGO 2025
Lung, Respiratory and Thoracic Cancer
ADRIATIC: Outcomes in long-term progression-free LS-SCLC survivors treated with durvalumab are associated with molecular characteristics of the tumor microenvironment
EHA 2025
Multiple Myeloma (MM)
CARTITUDE-4: Cilta-cel demonstrates superior survival outcomes across subgroups in lenalidomide-refractory MM
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Tasoudis P, Loufopoulos G, Manaki V, Doerr M, Agala CB, Long JM, Haithcock BE
doi: 10.1016/j.lungcan.2024.107929